Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-12-16

Clinical Trial Update: Does Peri-Operative Gabapentin Reduce Chronic Post-Thoracotomy Pain? [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating peri-operative gabapentin for reducing chronic post-thoracotomy pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Post-thoracotomy Pain | Phase 3 | Status: WITHDRAWN